Interferon beta: Completed Phase II enrollment

Synairgen completed enrollment of about 150 exacerbation-prone asthmatics in a double-blind, placebo-controlled, U.K. Phase II trial (SG005) evaluating once-daily inhaled SNG001 for 14 days. Patients ...